Hematopoietic SH2 Domain Containing (HSH2D) (Middle Region) Peptide
HSH2D
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5673287
Quick Overview for Hematopoietic SH2 Domain Containing (HSH2D) (Middle Region) Peptide (ABIN5673287)
Target
HSH2D
(Hematopoietic SH2 Domain Containing (HSH2D))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- TQPCRQKDPA NVDYEDLFLY SNAVAEEAAC PVSAPEEASP KPVLCHQSKE
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- HSH2D Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
-
Background
-
T-cell activation requires 2 signals: recognition of antigen by the T-cell receptor and a costimulatory signal provided primarily by CD28 in naive T cells. HSH2 is a target of both of these signaling pathways.
Alias Symbols: ALX, HSH2
Protein Size: 295 -
Gene ID
- 84941
-
NCBI Accession
- NM_001291274, NP_001278203
Target
-
You are here:
